5-nitro-o-toluidine

We are 5-nitro-o-toluidine CAS:99-55-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 5-nitro-o-toluidine
CAS.NO:99-55-8
Synonyms: 2-methyl-5-nitro-Benzenamine;devolscarletb;2-Methyl-5-nitroaniline;2-Methyl-5-nitrobenzolamin;2-methyl-5-nitrobenzenamine
Molecular Formula:C7H8N2O2
Molecular Weight:152.15100
 
Physical and Chemical Properties:
Density:1.269g/cm3
Boiling point:329.4ºC at 760 mmHg
Melting point:103-106 °C(lit.)
Flash point:153ºC
Index of Refraction:1.616
 
Specification:
Appearance:Yellow powder
Purity:≥99.0%
 
Packing: 25kg drum
Storage:Storage conditions:2-8°C.Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:An intermediate for organic pigments.
 

5-nitro-o-toluidine


Related News: The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.197145-37-2 The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.5-fluoro-2-metil-3-nitrobenzoato de metilo CAS:697739-03-0 Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.2-cloro-4- (dibenzo [b, d] furan-2-il) -6-fenil-1,3,5-triazina CAS:1618107-00-8 Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.

Related Products
Product Name
(1-Hydroxycyclohexyl)(4-methoxyphenyl)acetonitrile View Details
2-(Trifluoromethoxy)nitrobenzene View Details
Dimethoxydiphenylsilane View Details
(3-chlorophenyl)-(3,4-dimethoxyphenyl)methanone manufacturer 4-Methyl-2-(trifluoromethyl)aniline manufacturer Estra-5(10),9(11)-diene-3,17-dione 3-Ethylene Ketal manufacturer 2-Fluoro-4-iodobenzonitrile manufacturer 7-Chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid manufacturer